佐西隆 - - 提阿索利丁混合物:在寻找抗癌剂的过程中,一个新的类别
Eliza de Lucas Chazin1, Ligia Souza da Silveira Pinto1, Victor Facchinetti2
1Department of Organic Chemistry, Federal Fluminense University, Niterói-RJ, Brazil.
研究人员合成了15种佐西醇- thiazolidinones,并发现两种化合物对K562白血病细胞有效. 这些混合物显示出潜在的新型抗癌药物,向白血病.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 癌症仍然是全球主要的死亡原因,迫切需要开发新的向治疗方法.
- 迫切需要更强效和更具体的抗癌疗法来改善患者的治疗结果.
研究的目的:
- 为了合成新型的佐西 - - 提阿索利丁混合体.
- 评估这些化合物的细胞毒性活动与各种人类癌症细胞系对比.
- 为了确定潜在的化合物用于抗癌药物开发.
主要方法:
- 通过多步骤的方法合成了一系列15种佐西 - 阿丁混合物.
- 对5个人类癌细胞系 (胃,黑色素瘤,结肠,舌头,白血病) 和1个非瘤细胞系进行了细胞毒性评估.
- 进行了分子对接研究,以预测活性化合物的结合相互作用.
主要成果:
- 两种合成的化合物对K562白血病细胞系表现出显著的活性,IC50值为4.0μM和5.3μM.
- 对接分析表明,这些化合物可能向BCRABL1激酶,这与慢性髓性白血病 (CML) 有关.
结论:
- 佐西 - 提阿索利丁混合物显示出作为潜在的抗癌药物,特别是针对白血病的承诺.
- 对这些化合物的进一步研究可能会导致对CML的新治疗策略的开发.
- 这些已识别的化合物代表了优化抗癌药物候选者的有价值的起点.
更多相关视频
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
